tradingkey.logo

Anbio Biotechnology

NNNN
View Detailed Chart
25.650USD
+1.590+6.61%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.13BMarket Cap
416.53P/E TTM

Anbio Biotechnology

25.650
+1.590+6.61%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.61%

5 Days

+17.07%

1 Month

-20.07%

6 Months

-42.42%

Year to Date

-14.70%

1 Year

0.00%

View Detailed Chart

TradingKey Stock Score

No stock score available due to insufficient data.

Anbio Biotechnology News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Anbio Biotechnology Info

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
Ticker SymbolNNNN
CompanyAnbio Biotechnology
CEOLau (Michael)
Websitehttps://anbiobiotechnology.com/
KeyAI